ImpediMed Limited (ASX:IPD)
Australia
· Delayed Price · Currency is AUD 0.0160
-0.0010 (-5.88%)
At close: Mar 6, 2026
ImpediMed Revenue
ImpediMed had revenue of 7.52M AUD in the half year ending December 31, 2025, with 57.11% growth. This brings the company's revenue in the last twelve months to 14.23M, up 23.30% year-over-year. In the fiscal year ending June 30, 2025, ImpediMed had annual revenue of 12.72M with 23.31% growth.
Revenue (ttm)
14.23M
Revenue Growth
+23.30%
P/S Ratio
2.29
Revenue / Employee
184.83K
Employees
77
Market Cap
32.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12.72M | 2.41M | 23.31% |
| Jun 30, 2024 | 10.32M | -1.03M | -9.04% |
| Jun 30, 2023 | 11.34M | 778.00K | 7.36% |
| Jun 30, 2022 | 10.57M | 2.16M | 25.65% |
| Jun 30, 2021 | 8.41M | 2.67M | 46.47% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Atomo Diagnostics | 3.92M |
| CurveBeam AI | 12.15M |
| CleanSpace Holdings | 20.66M |
| Nova Eye Medical | 33.05M |
| Control Bionics | 6.07M |
| HeraMED | 431.61K |
| Micro-X | 16.90M |
| CONNEQT Health | 5.80M |
ImpediMed News
- 5 weeks ago - ImpediMed Limited (IPDQF) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 4 months ago - ImpediMed Limited (IPDQF) Q1 2026 Earnings Call Transcript - Seeking Alpha